Healthcare

Siemens to bring advanced timing constraint capabilities to EDA design flow with Excellicon acquisition

Acquisition enables System-on-a-Chip (SoC) designers to accelerate design closure and enhance functional and structural constraint correctness with industry-proven timing constraints…

7 months ago

Guidehouse Expands Chennai Footprint with New 250k sq. ft. Facility

State-of-the-art campus at Keppel One Paramount to host 5,000 employees across key operations; Facility will serve as a center for…

7 months ago

Pediatrics Open Science Launches Webinar for Early-Career Researchers

Pediatrics Open Science webinar will offer insights on manuscript preparation for those eager to navigate the world of academic publishing …

7 months ago

Vitalograph and Thorasys Forge Strategic Partnership to Expand Respiratory Diagnostics with Launch of Tremoflo® C2 Oscillometer

SAN FRANCISCO, May 19, 2025 /PRNewswire/ -- At the American Thoracic Society (ATS) Annual Conference, Vitalograph and Thorasys announced a…

7 months ago

Baird Medical Engages Global Clinical Leaders at AAES 2025

NEW YORK, May 19, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a…

7 months ago

Dazos Raises $25 Million Series A to Empower Behavioral Health Providers

BOCA RATON, Fla., May 19, 2025 /PRNewswire/ -- Dazos, the all-in-one CRM platform for behavioral health providers, has raised $25…

7 months ago

Olympus Appoints Slawek Kierner as Chief Digital Officer – Smart Connected Care

Newly created role to lead digital innovation TOKYO, May 19, 2025 /PRNewswire/ -- Olympus Corporation (Olympus), a global MedTech company committed to…

7 months ago

Cortechs.ai and ALZ-NET Announce Strategic Collaboration to Improve Alzheimer’s Disease Care Through AI-Driven Imaging

SAN DIEGO, May 19, 2025 /PRNewswire/ -- Cortechs.ai, a global leader in AI-driven neuroimaging solutions, today announced a strategic collaboration…

7 months ago

vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin

HIGH POINT, N.C., May 19, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced…

7 months ago

Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer

Press release – No. 9 / 2025 Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related…

7 months ago